株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

OTC医薬品産業:世界の産業ガイド

OTC Pharmaceuticals: Global Industry Guide 2016

発行 MarketLine 商品コード 143045
出版日 ページ情報 英文 271 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
OTC医薬品産業:世界の産業ガイド OTC Pharmaceuticals: Global Industry Guide 2016
出版日: 2016年10月18日 ページ情報: 英文 271 Pages
概要

当レポートは、世界におけるOTC医薬品産業について、地域/国別の市場販売額、販売量、市場区分、市場予測などを検証し、企業プロファイルを盛り込んで、概略下記の構成でお届けいたします。

エグゼクティブサマリー

イントロダクション

世界のOTC医薬品産業

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測

アジア太平洋地域

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測

欧州

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測

ベルギー

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

カナダ

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

中国

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

フランス

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

ドイツ

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

イタリア

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

日本

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

オランダ

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

スペイン

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

英国

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

米国

  • 市場概要
  • 市場販売額
  • 市場区分?
  • 市場区分?
  • 市場シェア
  • ファイブフォース分析
  • 市場流通
  • 市場予測
  • マクロ経済指標

企業プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MLIG16046-06

Summary

Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global otc pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global otc pharmaceuticals market
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global otc pharmaceuticals market with five year forecasts by both value and volume

Synopsis

Essential resource for top-line data and analysis covering the global otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

Reasons To Buy

  • What was the size of the global otc pharmaceuticals market by value in 2015?
  • What will be the size of the global otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the global otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global otc pharmaceuticals market?

Key Highlights

  • The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.
  • The global OTC pharmaceuticals market generated total revenues of $130,434.6m in 2015, representing a CARC of -1.0% between 2011 and 2015.
  • Traditional medicines registered the highest sales value in the global OTC pharmaceuticals market in 2015, with total sales of $23,987.7m, equivalent to 18.4% of the market's overall value.
  • The largest regional market globally is Asia-Pacific, although the US remains the largest individual country at 29.7% of the market in 2015.

Table of Contents

EXECUTIVE SUMMARY

  • Market value
  • Market value forecast
  • Category segmentation
  • Geography segmentation
  • Market share

Introduction

  • What is this report about?
  • Who is the target reader?
  • How to use this report
  • Definitions

Global OTC Pharmaceuticals

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

OTC Pharmaceuticals in Asia-Pacific

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

OTC Pharmaceuticals in Europe

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

OTC Pharmaceuticals in France

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in Germany

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in Italy

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in Japan

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in Australia

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in Canada

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in China

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in The Netherlands

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in Spain

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in The United Kingdom

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

OTC Pharmaceuticals in The United States

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Company Profiles
  • Leading companies

Appendix

  • Methodology
  • About MarketLine

List of Tables

  • Table 1: Global OTC pharmaceuticals market value: $ million, 2011-15
  • Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 3: Global OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 4: Global OTC pharmaceuticals market share: % share, by value, 2015
  • Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 6: Global OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 7: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011-15
  • Table 8: Asia-Pacific OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 9: Asia-Pacific OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 10: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
  • Table 11: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 12: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 13: Europe OTC pharmaceuticals market value: $ million, 2011-15
  • Table 14: Europe OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 15: Europe OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 16: Europe OTC pharmaceuticals market share: % share, by value, 2015
  • Table 17: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 18: Europe OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 19: France OTC pharmaceuticals market value: $ million, 2011-15
  • Table 20: France OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 21: France OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 22: France OTC pharmaceuticals market share: % share, by value, 2015
  • Table 23: France OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 24: France OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 25: France size of population (million), 2011-15
  • Table 26: France gdp (constant 2005 prices, $ billion), 2011-15
  • Table 27: France gdp (current prices, $ billion), 2011-15
  • Table 28: France inflation, 2011-15
  • Table 29: France consumer price index (absolute), 2011-15
  • Table 30: France exchange rate, 2011-15
  • Table 31: Germany OTC pharmaceuticals market value: $ million, 2011-15
  • Table 32: Germany OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 33: Germany OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 34: Germany OTC pharmaceuticals market share: % share, by value, 2015
  • Table 35: Germany OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 36: Germany OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 37: Germany size of population (million), 2011-15
  • Table 38: Germany gdp (constant 2005 prices, $ billion), 2011-15
  • Table 39: Germany gdp (current prices, $ billion), 2011-15
  • Table 40: Germany inflation, 2011-15
  • Table 41: Germany consumer price index (absolute), 2011-15
  • Table 42: Germany exchange rate, 2011-15
  • Table 43: Italy OTC pharmaceuticals market value: $ million, 2011-15
  • Table 44: Italy OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 45: Italy OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 46: Italy OTC pharmaceuticals market share: % share, by value, 2015
  • Table 47: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 48: Italy OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 49: Italy size of population (million), 2011-15
  • Table 50: Italy gdp (constant 2005 prices, $ billion), 2011-15
  • Table 51: Italy gdp (current prices, $ billion), 2011-15
  • Table 52: Italy inflation, 2011-15
  • Table 53: Italy consumer price index (absolute), 2011-15
  • Table 54: Italy exchange rate, 2011-15
  • Table 55: Japan OTC pharmaceuticals market value: $ million, 2011-15
  • Table 56: Japan OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 57: Japan OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 58: Japan OTC pharmaceuticals market share: % share, by value, 2015
  • Table 59: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 60: Japan OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 61: Japan size of population (million), 2011-15
  • Table 62: Japan gdp (constant 2005 prices, $ billion), 2011-15
  • Table 63: Japan gdp (current prices, $ billion), 2011-15
  • Table 64: Japan inflation, 2011-15
  • Table 65: Japan consumer price index (absolute), 2011-15
  • Table 66: Japan exchange rate, 2011-15
  • Table 67: Australia OTC pharmaceuticals market value: $ million, 2011-15
  • Table 68: Australia OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 69: Australia OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 70: Australia OTC pharmaceuticals market share: % share, by value, 2015
  • Table 71: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 72: Australia OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 73: Australia size of population (million), 2011-15
  • Table 74: Australia gdp (constant 2005 prices, $ billion), 2011-15
  • Table 75: Australia gdp (current prices, $ billion), 2011-15
  • Table 76: Australia inflation, 2011-15
  • Table 77: Australia consumer price index (absolute), 2011-15
  • Table 78: Australia exchange rate, 2011-15
  • Table 79: Canada OTC pharmaceuticals market value: $ million, 2011-15
  • Table 80: Canada OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 81: Canada OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 82: Canada OTC pharmaceuticals market share: % share, by value, 2015
  • Table 83: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 84: Canada OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 85: Canada size of population (million), 2011-15
  • Table 86: Canada gdp (constant 2005 prices, $ billion), 2011-15
  • Table 87: Canada gdp (current prices, $ billion), 2011-15
  • Table 88: Canada inflation, 2011-15
  • Table 89: Canada consumer price index (absolute), 2011-15
  • Table 90: Canada exchange rate, 2011-15
  • Table 91: China OTC pharmaceuticals market value: $ million, 2011-15
  • Table 92: China OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 93: China OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 94: China OTC pharmaceuticals market share: % share, by value, 2015
  • Table 95: China OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 96: China OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 97: China size of population (million), 2011-15
  • Table 98: China gdp (constant 2005 prices, $ billion), 2011-15
  • Table 99: China gdp (current prices, $ billion), 2011-15
  • Table 100: China inflation, 2011-15
  • Table 101: China consumer price index (absolute), 2011-15
  • Table 102: China exchange rate, 2011-15
  • Table 103: Netherlands OTC pharmaceuticals market value: $ million, 2011-15
  • Table 104: Netherlands OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 105: Netherlands OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 106: Netherlands OTC pharmaceuticals market share: % share, by value, 2015
  • Table 107: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 108: Netherlands OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 109: Netherlands size of population (million), 2011-15
  • Table 110: Netherlands gdp (constant 2005 prices, $ billion), 2011-15
  • Table 111: Netherlands gdp (current prices, $ billion), 2011-15
  • Table 112: Netherlands inflation, 2011-15
  • Table 113: Netherlands consumer price index (absolute), 2011-15
  • Table 114: Netherlands exchange rate, 2011-15
  • Table 115: Spain OTC pharmaceuticals market value: $ million, 2011-15
  • Table 116: Spain OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 117: Spain OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 118: Spain OTC pharmaceuticals market share: % share, by value, 2015
  • Table 119: Spain OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 120: Spain OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 121: Spain size of population (million), 2011-15
  • Table 122: Spain gdp (constant 2005 prices, $ billion), 2011-15
  • Table 123: Spain gdp (current prices, $ billion), 2011-15
  • Table 124: Spain inflation, 2011-15
  • Table 125: Spain consumer price index (absolute), 2011-15
  • Table 126: Spain exchange rate, 2011-15
  • Table 127: United Kingdom OTC pharmaceuticals market value: $ million, 2011-15
  • Table 128: United Kingdom OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 129: United Kingdom OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 130: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015
  • Table 131: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 132: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 133: United Kingdom size of population (million), 2011-15
  • Table 134: United Kingdom gdp (constant 2005 prices, $ billion), 2011-15
  • Table 135: United Kingdom gdp (current prices, $ billion), 2011-15
  • Table 136: United Kingdom inflation, 2011-15
  • Table 137: United Kingdom consumer price index (absolute), 2011-15
  • Table 138: United Kingdom exchange rate, 2011-15
  • Table 139: United States OTC pharmaceuticals market value: $ million, 2011-15
  • Table 140: United States OTC pharmaceuticals market category segmentation: $ million, 2015
  • Table 141: United States OTC pharmaceuticals market geography segmentation: $ million, 2015
  • Table 142: United States OTC pharmaceuticals market share: % share, by value, 2015
  • Table 143: United States OTC pharmaceuticals market distribution: % share, by value, 2015
  • Table 144: United States OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Table 145: United States size of population (million), 2011-15
  • Table 146: United States gdp (constant 2005 prices, $ billion), 2011-15
  • Table 147: United States gdp (current prices, $ billion), 2011-15
  • Table 148: United States inflation, 2011-15
  • Table 149: United States consumer price index (absolute), 2011-15
  • Table 150: United States exchange rate, 2011-15
  • Table 151: Bayer AG: key facts
  • Table 152: Bayer AG: key financials ($)
  • Table 153: Bayer AG: key financials (€)
  • Table 154: Bayer AG: key financial ratios
  • Table 155: GlaxoSmithKline Plc: key facts
  • Table 156: GlaxoSmithKline Plc: key financials ($)
  • Table 157: GlaxoSmithKline Plc: key financials (£)
  • Table 158: GlaxoSmithKline Plc: key financial ratios
  • Table 159: Johnson & Johnson: key facts
  • Table 160: Johnson & Johnson: key financials ($)
  • Table 161: Johnson & Johnson: key financial ratios
  • Table 162: Novartis AG: key facts
  • Table 163: Novartis AG: key financials ($)
  • Table 164: Novartis AG: key financial ratios
  • Table 165: Nin Jiom Medicines Manufactory Ltd: key facts
  • Table 166: The Procter & Gamble Company: key facts
  • Table 167: The Procter & Gamble Company: key financials ($)
  • Table 168: The Procter & Gamble Company: key financial ratios
  • Table 169: Reckitt Benckiser Group plc: key facts
  • Table 170: Reckitt Benckiser Group plc: key financials ($)
  • Table 171: Reckitt Benckiser Group plc: key financials (£)
  • Table 172: Reckitt Benckiser Group plc: key financial ratios
  • Table 173: Sanofi SA: key facts
  • Table 174: Sanofi SA: key financials ($)
  • Table 175: Sanofi SA: key financials (€)
  • Table 176: Sanofi SA: key financial ratios
  • Table 177: Almirall S.A.: key facts
  • Table 178: Almirall S.A.: key financials ($)
  • Table 179: Almirall S.A.: key financials (€)
  • Table 180: Almirall S.A.: key financial ratios
  • Table 181: Boehringer Ingelheim GmbH: key facts
  • Table 182: Boehringer Ingelheim GmbH: key financials ($)
  • Table 183: Boehringer Ingelheim GmbH: key financials (€)
  • Table 184: Boehringer Ingelheim GmbH: key financial ratios
  • Table 185: Daiichi Sankyo Co., Ltd.: key facts
  • Table 186: Daiichi Sankyo Co., Ltd.: key financials ($)
  • Table 187: Daiichi Sankyo Co., Ltd.: key financials (¥)
  • Table 188: Daiichi Sankyo Co., Ltd.: key financial ratios
  • Table 189: Kracie Holdings, Ltd.: key facts
  • Table 190: Pfizer Inc.: key facts
  • Table 191: Pfizer Inc.: key financials ($)
  • Table 192: Pfizer Inc.: key financial ratios
  • Table 193: Suntory Group: key facts
  • Table 194: Suntory Group: key financials ($)
  • Table 195: Suntory Group: key financials (¥)
  • Table 196: Suntory Group: key financial ratios
  • Table 197: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts

List of Figures

  • Figure 1: Global OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 3: Global OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 4: Global OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 6: Global OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 7: Forces driving competition in the global OTC pharmaceuticals market, 2015
  • Figure 8: Drivers of buyer power in the global OTC pharmaceuticals market, 2015
  • Figure 9: Drivers of supplier power in the global OTC pharmaceuticals market, 2015
  • Figure 10: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2015
  • Figure 11: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2015
  • Figure 12: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2015
  • Figure 13: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 14: Asia-Pacific OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 15: Asia-Pacific OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 16: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 17: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 18: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 19: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2015
  • Figure 20: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2015
  • Figure 21: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2015
  • Figure 22: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2015
  • Figure 23: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2015
  • Figure 24: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2015
  • Figure 25: Europe OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 26: Europe OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 27: Europe OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 28: Europe OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 29: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 30: Europe OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 31: Forces driving competition in the OTC pharmaceuticals market in Europe, 2015
  • Figure 32: Drivers of buyer power in the OTC pharmaceuticals market in Europe, 2015
  • Figure 33: Drivers of supplier power in the OTC pharmaceuticals market in Europe, 2015
  • Figure 34: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Europe, 2015
  • Figure 35: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Europe, 2015
  • Figure 36: Drivers of degree of rivalry in the OTC pharmaceuticals market in Europe, 2015
  • Figure 37: France OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 38: France OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 39: France OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 40: France OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 41: France OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 42: France OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 43: Forces driving competition in the OTC pharmaceuticals market in France, 2015
  • Figure 44: Drivers of buyer power in the OTC pharmaceuticals market in France, 2015
  • Figure 45: Drivers of supplier power in the OTC pharmaceuticals market in France, 2015
  • Figure 46: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in France, 2015
  • Figure 47: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in France, 2015
  • Figure 48: Drivers of degree of rivalry in the OTC pharmaceuticals market in France, 2015
  • Figure 49: Germany OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 50: Germany OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 51: Germany OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 52: Germany OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 53: Germany OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 54: Germany OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 55: Forces driving competition in the OTC pharmaceuticals market in Germany, 2015
  • Figure 56: Drivers of buyer power in the OTC pharmaceuticals market in Germany, 2015
  • Figure 57: Drivers of supplier power in the OTC pharmaceuticals market in Germany, 2015
  • Figure 58: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Germany, 2015
  • Figure 59: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Germany, 2015
  • Figure 60: Drivers of degree of rivalry in the OTC pharmaceuticals market in Germany, 2015
  • Figure 61: Italy OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 62: Italy OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 63: Italy OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 64: Italy OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 65: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 66: Italy OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 67: Forces driving competition in the OTC pharmaceuticals market in Italy, 2015
  • Figure 68: Drivers of buyer power in the OTC pharmaceuticals market in Italy, 2015
  • Figure 69: Drivers of supplier power in the OTC pharmaceuticals market in Italy, 2015
  • Figure 70: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Italy, 2015
  • Figure 71: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Italy, 2015
  • Figure 72: Drivers of degree of rivalry in the OTC pharmaceuticals market in Italy, 2015
  • Figure 73: Japan OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 74: Japan OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 75: Japan OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 76: Japan OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 77: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 78: Japan OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 79: Forces driving competition in the OTC pharmaceuticals market in Japan, 2015
  • Figure 80: Drivers of buyer power in the OTC pharmaceuticals market in Japan, 2015
  • Figure 81: Drivers of supplier power in the OTC pharmaceuticals market in Japan, 2015
  • Figure 82: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Japan, 2015
  • Figure 83: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Japan, 2015
  • Figure 84: Drivers of degree of rivalry in the OTC pharmaceuticals market in Japan, 2015
  • Figure 85: Australia OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 86: Australia OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 87: Australia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 88: Australia OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 89: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 90: Australia OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 91: Forces driving competition in the OTC pharmaceuticals market in Australia, 2015
  • Figure 92: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2015
  • Figure 93: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2015
  • Figure 94: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2015
  • Figure 95: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2015
  • Figure 96: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2015
  • Figure 97: Canada OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 98: Canada OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 99: Canada OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 100: Canada OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 101: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 102: Canada OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 103: Forces driving competition in the OTC pharmaceuticals market in Canada, 2015
  • Figure 104: Drivers of buyer power in the OTC pharmaceuticals market in Canada, 2015
  • Figure 105: Drivers of supplier power in the OTC pharmaceuticals market in Canada, 2015
  • Figure 106: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Canada, 2015
  • Figure 107: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Canada, 2015
  • Figure 108: Drivers of degree of rivalry in the OTC pharmaceuticals market in Canada, 2015
  • Figure 109: China OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 110: China OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 111: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 112: China OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 113: China OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 114: China OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 115: Forces driving competition in the OTC pharmaceuticals market in China, 2015
  • Figure 116: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015
  • Figure 117: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015
  • Figure 118: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015
  • Figure 119: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015
  • Figure 120: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015
  • Figure 121: Netherlands OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 122: Netherlands OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 123: Netherlands OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 124: Netherlands OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 125: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 126: Netherlands OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 127: Forces driving competition in the OTC pharmaceuticals market in the Netherlands, 2015
  • Figure 128: Drivers of buyer power in the OTC pharmaceuticals market in the Netherlands, 2015
  • Figure 129: Drivers of supplier power in the OTC pharmaceuticals market in the Netherlands, 2015
  • Figure 130: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the Netherlands, 2015
  • Figure 131: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the Netherlands, 2015
  • Figure 132: Drivers of degree of rivalry in the OTC pharmaceuticals market in the Netherlands, 2015
  • Figure 133: Spain OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 134: Spain OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 135: Spain OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 136: Spain OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 137: Spain OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 138: Spain OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 139: Forces driving competition in the OTC pharmaceuticals market in Spain, 2015
  • Figure 140: Drivers of buyer power in the OTC pharmaceuticals market in Spain, 2015
  • Figure 141: Drivers of supplier power in the OTC pharmaceuticals market in Spain, 2015
  • Figure 142: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Spain, 2015
  • Figure 143: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Spain, 2015
  • Figure 144: Drivers of degree of rivalry in the OTC pharmaceuticals market in Spain, 2015
  • Figure 145: United Kingdom OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 146: United Kingdom OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 147: United Kingdom OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 148: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 149: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 150: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 151: Forces driving competition in the OTC pharmaceuticals market in the United Kingdom, 2015
  • Figure 152: Drivers of buyer power in the OTC pharmaceuticals market in the United Kingdom, 2015
  • Figure 153: Drivers of supplier power in the OTC pharmaceuticals market in the United Kingdom, 2015
  • Figure 154: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United Kingdom, 2015
  • Figure 155: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United Kingdom, 2015
  • Figure 156: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United Kingdom, 2015
  • Figure 157: United States OTC pharmaceuticals market value: $ million, 2011-15
  • Figure 158: United States OTC pharmaceuticals market category segmentation: % share, by value, 2015
  • Figure 159: United States OTC pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 160: United States OTC pharmaceuticals market share: % share, by value, 2015
  • Figure 161: United States OTC pharmaceuticals market distribution: % share, by value, 2015
  • Figure 162: United States OTC pharmaceuticals market value forecast: $ million, 2015-20
  • Figure 163: Forces driving competition in the OTC pharmaceuticals market in the United States, 2015
  • Figure 164: Drivers of buyer power in the OTC pharmaceuticals market in the United States, 2015
  • Figure 165: Drivers of supplier power in the OTC pharmaceuticals market in the United States, 2015
  • Figure 166: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United States, 2015
  • Figure 167: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United States, 2015
  • Figure 168: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United States, 2015
  • Figure 169: Bayer AG: revenues & profitability
  • Figure 170: Bayer AG: assets & liabilities
  • Figure 171: GlaxoSmithKline Plc: revenues & profitability
  • Figure 172: GlaxoSmithKline Plc: assets & liabilities
  • Figure 173: Johnson & Johnson: revenues & profitability
  • Figure 174: Johnson & Johnson: assets & liabilities
  • Figure 175: Novartis AG: revenues & profitability
  • Figure 176: Novartis AG: assets & liabilities
  • Figure 177: The Procter & Gamble Company: revenues & profitability
  • Figure 178: The Procter & Gamble Company: assets & liabilities
  • Figure 179: Reckitt Benckiser Group plc: revenues & profitability
  • Figure 180: Reckitt Benckiser Group plc: assets & liabilities
  • Figure 181: Sanofi SA: revenues & profitability
  • Figure 182: Sanofi SA: assets & liabilities
  • Figure 183: Almirall S.A.: revenues & profitability
  • Figure 184: Almirall S.A.: assets & liabilities
  • Figure 185: Boehringer Ingelheim GmbH: revenues & profitability
  • Figure 186: Boehringer Ingelheim GmbH: assets & liabilities
  • Figure 187: Daiichi Sankyo Co., Ltd.: revenues & profitability
  • Figure 188: Daiichi Sankyo Co., Ltd.: assets & liabilities
  • Figure 189: Pfizer Inc.: revenues & profitability
  • Figure 190: Pfizer Inc.: assets & liabilities
  • Figure 191: Suntory Group: revenues & profitability
  • Figure 192: Suntory Group: assets & liabilities
Back to Top